英伟达Q2持仓曝光：9成仓位豪赌CoreWeave

Core Insights - Nvidia has heavily invested in CoreWeave, allocating 91.36% of its public holdings, amounting to $3.96 billion, indicating a strong belief in AI cloud computing services [1][2] - CoreWeave's revenue for Q2 reached $1.2 billion, showing a year-over-year growth of over 300%, although its stock price recently dropped nearly 21% due to lower-than-expected revenue growth and increased capital expenditure plans [1][4] - The company is facing a significant unlock of approximately 84% of Class A shares, which may lead to market volatility [1][4] Investment Diversification - Besides CoreWeave, Nvidia holds stakes in several other AI-related companies, including Arm (4.11%), Applied Digital (1.79%), Nebius (1.52%), and Recursion Pharmaceuticals (0.90%) [3] - Arm is expanding its energy-efficient architecture into data centers, while Applied Digital focuses on high-performance computing infrastructure [3] - Recursion Pharmaceuticals applies machine learning in drug discovery, showcasing Nvidia's interest in AI-driven healthcare [3] Challenges Facing CoreWeave - CoreWeave is burdened with over $11 billion in total debt and is consuming cash while expanding its network [4] - Despite these challenges, the company has a strong customer base, with major tech firms like Microsoft and Meta increasing their capital expenditure forecasts [4] - CoreWeave has secured a $4 billion four-year expansion agreement with OpenAI and announced a $9 billion stock acquisition of Core Scientific [4]